NO20080554L - Pyrazolonderivater - Google Patents
PyrazolonderivaterInfo
- Publication number
- NO20080554L NO20080554L NO20080554A NO20080554A NO20080554L NO 20080554 L NO20080554 L NO 20080554L NO 20080554 A NO20080554 A NO 20080554A NO 20080554 A NO20080554 A NO 20080554A NO 20080554 L NO20080554 L NO 20080554L
- Authority
- NO
- Norway
- Prior art keywords
- pyrazolone
- esters
- compounds
- formula
- well
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
- C07D231/26—1-Phenyl-3-methyl-5- pyrazolones, unsubstituted or substituted on the phenyl ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05107970 | 2005-08-31 | ||
PCT/EP2006/065471 WO2007025880A2 (en) | 2005-08-31 | 2006-08-21 | Pyrazolone derivatives as 11-beta hsd1 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080554L true NO20080554L (no) | 2008-03-14 |
Family
ID=37729936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080554A NO20080554L (no) | 2005-08-31 | 2008-01-30 | Pyrazolonderivater |
Country Status (23)
Country | Link |
---|---|
US (1) | US7652057B2 (zh) |
EP (1) | EP1924562A2 (zh) |
JP (1) | JP5073664B2 (zh) |
KR (1) | KR100982088B1 (zh) |
CN (1) | CN101243050B (zh) |
AR (1) | AR055145A1 (zh) |
AU (1) | AU2006286646B2 (zh) |
BR (1) | BRPI0615039A2 (zh) |
CA (1) | CA2618840C (zh) |
CR (1) | CR9703A (zh) |
EC (1) | ECSP088229A (zh) |
HK (1) | HK1123295A1 (zh) |
IL (1) | IL189186A0 (zh) |
MA (1) | MA29775B1 (zh) |
MX (1) | MX2008002583A (zh) |
MY (1) | MY145464A (zh) |
NO (1) | NO20080554L (zh) |
NZ (1) | NZ565536A (zh) |
RU (1) | RU2407737C2 (zh) |
TW (1) | TWI332949B (zh) |
UA (1) | UA90742C2 (zh) |
WO (1) | WO2007025880A2 (zh) |
ZA (1) | ZA200801444B (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9145424B2 (en) | 2008-11-20 | 2015-09-29 | Northwestern University | Treatment of amyotrophic lateral sclerosis |
US9428467B2 (en) | 2008-11-20 | 2016-08-30 | Northwestern University | Selective calcium channel antagonists |
CA2744016C (en) | 2008-11-20 | 2018-12-11 | Cambria Pharmaceuticals, Inc. | Treatment of amyotrophic lateral sclerosis |
ES2423668T3 (es) | 2009-05-22 | 2013-09-23 | Abbvie Inc. | Moduladores de receptores 5-HT y métodos de uso de los mismos |
WO2011051958A1 (en) | 2009-10-30 | 2011-05-05 | E.I. Du Pont De Nemours And Company | Fungicidal pyrazolones |
CN103002735B (zh) * | 2010-05-21 | 2015-05-20 | Abbvie公司 | 5-ht受体的调节剂和其使用方法 |
EP2881388A1 (en) | 2013-12-09 | 2015-06-10 | Basf Se | Pyrazolone compounds having herbicidal activity |
EP2881387A1 (en) | 2013-12-09 | 2015-06-10 | Basf Se | Pyrazolone compounds having herbicidal activity |
EP3235813A1 (en) | 2016-04-19 | 2017-10-25 | Cidqo 2012, S.L. | Aza-tetra-cyclo derivatives |
WO2019048988A1 (en) | 2017-09-08 | 2019-03-14 | Pi Industries Ltd. | NOVEL FUNGICIDE HETEROCYCLIC COMPOUNDS |
CN111655687A (zh) | 2017-09-08 | 2020-09-11 | Pi工业有限公司 | 新型杀真菌杂环化合物 |
CA3136838A1 (en) * | 2019-04-17 | 2020-10-22 | Pontificia Universidad Catolica De Chile | Derivatives of adamantyl oxadiazoles and pharmaceutically acceptable solvates, hydrates and salts thereof, pharmaceutical composition comprising same, synthesis method, suitable for use as effective and selective inhibitors of the reductase activity of the enzyme 11-beta dehydrogenase type 1 (11.beta.-hsd1) |
CN113527207B (zh) * | 2020-04-22 | 2023-06-06 | 常州强力电子新材料股份有限公司 | 乙氧基/丙氧基改性的吡唑啉有机物、其应用、光固化组合物及光刻胶 |
CN112375072B (zh) * | 2020-09-28 | 2021-05-28 | 上海长征富民金山制药有限公司 | 吡唑啉酮衍生物、注射剂及其用途 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2731473A (en) * | 1956-01-17 | New pyrazolone derivatives | ||
DE668628C (de) * | 1935-12-08 | 1938-12-07 | Beiersdorf & Co A G P | Verfahren zur Darstellung von Alkyl- und Aralkylabkoemmlingen der 3,4-Cyclotetramethylen-1-aryl-5-pyrazolone |
JPS609752B2 (ja) * | 1979-11-09 | 1985-03-12 | 東邦新薬株式会社 | 新規な2−アセトキシベンズアミド誘導体、その製法及びそれを有効成分とする医薬 |
DE4415484A1 (de) | 1994-05-03 | 1995-11-09 | Basf Ag | Verfahren zur Herstellung von 1-(Het)aryl-3-hydroxy-pyrazolen |
US5663365A (en) | 1996-10-29 | 1997-09-02 | Japan Hydrazine Co., Ltd. | Process for the preparation of pyrazolones |
DK0870757T3 (da) | 1997-04-10 | 2002-07-15 | Pfizer | Fluorsubstituerede adamantanderivater |
TW536387B (en) | 1998-04-23 | 2003-06-11 | Sumitomo Chemical Co | Pyrazolinone compound |
AU782330B2 (en) * | 1999-08-31 | 2005-07-21 | Kissei Pharmaceutical Co. Ltd. | Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof |
ATE431830T1 (de) * | 2000-12-28 | 2009-06-15 | Kissei Pharmaceutical | Glucopyranosylpyrazolderivate und deren verwendung in arzneimitteln |
EP1541564A1 (en) * | 2002-09-10 | 2005-06-15 | Takeda Pharmaceutical Company Limited | Five-membered heterocyclic compounds |
AU2003303210A1 (en) | 2002-12-19 | 2004-07-14 | Bristol-Myers Squibb Company | Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
GB0306718D0 (en) * | 2003-03-24 | 2003-04-30 | Sterix Ltd | Compound |
CN1832741A (zh) * | 2003-08-07 | 2006-09-13 | 默克公司 | 作为11-β-羟甾类脱氢酶-1抑制剂的吡唑甲酰胺类 |
-
2006
- 2006-08-21 JP JP2008528461A patent/JP5073664B2/ja not_active Expired - Fee Related
- 2006-08-21 NZ NZ565536A patent/NZ565536A/en not_active IP Right Cessation
- 2006-08-21 MX MX2008002583A patent/MX2008002583A/es active IP Right Grant
- 2006-08-21 AU AU2006286646A patent/AU2006286646B2/en not_active Ceased
- 2006-08-21 EP EP06792909A patent/EP1924562A2/en not_active Withdrawn
- 2006-08-21 BR BRPI0615039-0A patent/BRPI0615039A2/pt not_active IP Right Cessation
- 2006-08-21 KR KR1020087004807A patent/KR100982088B1/ko not_active IP Right Cessation
- 2006-08-21 UA UAA200803780A patent/UA90742C2/ru unknown
- 2006-08-21 CN CN2006800305234A patent/CN101243050B/zh not_active Expired - Fee Related
- 2006-08-21 CA CA2618840A patent/CA2618840C/en not_active Expired - Fee Related
- 2006-08-21 MY MYPI20080416A patent/MY145464A/en unknown
- 2006-08-21 RU RU2008111971/04A patent/RU2407737C2/ru not_active IP Right Cessation
- 2006-08-21 WO PCT/EP2006/065471 patent/WO2007025880A2/en active Application Filing
- 2006-08-29 TW TW095131856A patent/TWI332949B/zh not_active IP Right Cessation
- 2006-08-29 AR ARP060103758A patent/AR055145A1/es unknown
- 2006-08-29 US US11/511,542 patent/US7652057B2/en not_active Expired - Fee Related
-
2008
- 2008-01-29 CR CR9703A patent/CR9703A/es not_active Application Discontinuation
- 2008-01-30 NO NO20080554A patent/NO20080554L/no not_active Application Discontinuation
- 2008-02-03 IL IL189186A patent/IL189186A0/en unknown
- 2008-02-12 ZA ZA200801444A patent/ZA200801444B/xx unknown
- 2008-02-27 EC EC2008008229A patent/ECSP088229A/es unknown
- 2008-03-14 MA MA30744A patent/MA29775B1/fr unknown
-
2009
- 2009-02-03 HK HK09100950.9A patent/HK1123295A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2006286646A1 (en) | 2007-03-08 |
HK1123295A1 (en) | 2009-06-12 |
JP5073664B2 (ja) | 2012-11-14 |
US20070049574A1 (en) | 2007-03-01 |
ZA200801444B (en) | 2008-12-31 |
CR9703A (es) | 2008-02-20 |
MX2008002583A (es) | 2008-03-18 |
BRPI0615039A2 (pt) | 2011-04-26 |
MA29775B1 (fr) | 2008-09-01 |
IL189186A0 (en) | 2008-06-05 |
CA2618840C (en) | 2011-07-05 |
NZ565536A (en) | 2011-03-31 |
TWI332949B (en) | 2010-11-11 |
AR055145A1 (es) | 2007-08-08 |
US7652057B2 (en) | 2010-01-26 |
UA90742C2 (en) | 2010-05-25 |
CN101243050B (zh) | 2012-07-04 |
KR100982088B1 (ko) | 2010-09-13 |
CA2618840A1 (en) | 2007-03-08 |
WO2007025880A3 (en) | 2007-05-03 |
RU2407737C2 (ru) | 2010-12-27 |
EP1924562A2 (en) | 2008-05-28 |
WO2007025880A2 (en) | 2007-03-08 |
ECSP088229A (es) | 2008-03-26 |
RU2008111971A (ru) | 2009-10-10 |
JP2009506089A (ja) | 2009-02-12 |
TW200740764A (en) | 2007-11-01 |
KR20080031482A (ko) | 2008-04-08 |
CN101243050A (zh) | 2008-08-13 |
MY145464A (en) | 2012-02-15 |
AU2006286646B2 (en) | 2010-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20080554L (no) | Pyrazolonderivater | |
NO20071617L (no) | Indozolonderivater som 11B-HSD1-inhibitorer | |
NO20070445L (no) | Pyrimidinderivater. | |
NO20091548L (no) | Imidazolon- og imidazolidinonderivater som 11B-HSD1 inhibitorer for diabetes | |
NO20071658L (no) | Alkil-pyridiner som 11-beta-inhibitorer for diabetes | |
NO20070458L (no) | Aryl-pyridinderivater som 11-Beta-HSD1 inhibitorer | |
TW200738241A (en) | Pyridazine derivatives | |
NO20076648L (no) | Novel thiophene derivatives | |
NO20084418L (no) | Azolopyridin-3-on derivater som inhibitorer av endoteliallipase | |
NO20082159L (no) | Triazolopyridinderivater som inhibitorer av lipaser og fosfolipaser | |
MX2012000414A (es) | Derivados piridin-4-ilo. | |
NO20082388L (no) | Heteroaryl substituerte piperidinderivater som L-CPT1 inhibitorer | |
NO20083514L (no) | Heterobicykliske sulfonamidderivater for behandling av diabetes | |
NO20082561L (no) | Nye koblede pyrrolderivater | |
MX2010005824A (es) | Derivados de aminotiazol. | |
NO20070089L (no) | DPP-IV inhibitorer | |
WO2007046867A3 (en) | Piperidine derivatives and their uses as therapeutic agents | |
NO20050667L (no) | N-substituerte-1H-indol-5-propionsyreforbindelser som PPAR agonister nyttige for behandling av diabetes | |
WO2009068468A3 (en) | Pyridine compounds | |
NO20083708L (no) | 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer | |
MX2009003169A (es) | Derivados de sulfonamida. | |
NO20084543L (no) | Benzimidazolderivater | |
NO20080133L (no) | Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer | |
WO2009106599A3 (en) | Substituted piperidines as therapeutic compounds | |
MX2009013003A (es) | Derivados de piperidina-amida. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |